HYBRID PEPTIDE A NEW CLINICAL FRONTIER

Chimera molecules represent a increasingly developing area in drug research, providing a distinct method to address previously intractable diseases. Such designed structures merge several protein segments, allowing for optimized binding to several sites and possibly circumventing drug resistance.